What this trial studies
During the new coronavirus-19 (COVID-19) pandemic, assessing the effects of online aerobic exercise on physical performance and health-related quality of life (HRQoL) in adults has garnered significant interest. This study, which investigated the impact of four-week online aerobic exercise on physical performance and HRQoL in non-diagnosed COVID-19 adults, provides crucial insights. After the study was completed, the four-week online exercise program did not significantly enhance physical performance and HRQoL but increased physical activity. These findings are important for understanding the potential of online aerobic exercise.
Conditions in scope
- Exercise
Interventions
- Online aerobic exercise (Other) — Before starting the online aerobic exercises, for general warm-up, two minutes of walking, one minute of marching, and ten repetitions of bilateral reciprocal shoulder flexion-extension, shoulder horizontal abduction-adduction, and unilateral shoulder flexion and circling exercises were performed. For the upper…
Who can join
All sexes · Ages 40 Years to 60 Years · Accepts healthy volunteers.
Inclusion criteria
- Not diagnosed with COVID-19,
- Being between 40-60 years of age,
- Having a medium level of physical activity according to the International Physical Activity Questionnaire-Short Form (IPAQ-SF),
- Not having any mental or physical problem preventing walking, running, or jumping,
- Residing in the Muş and Denizli city provinces,
- Being able to speak and understand the local language,
- Being able to understand verbal and written information given.
Exclusion criteria
- Having an injury/injury affecting the lower or upper extremities within the last six months,
- Participating in any exercise or strengthening training within the previous three months.
Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.
Where it’s happening
| City | State / Region | Facility | Site status |
|---|---|---|---|
| Muş | Muş and Denizli Province | Muş Alparslan University | Unknown |
Status & timeline
- Overall status: Completed
- Study type: Interventional
- Phase: N/A
- Start date: 2022-06-01
- Primary completion: 2023-07-01
- Last update posted: 2024-11-20
- First posted: 2024-07-24
Sponsor & contact
Lead sponsor: Muş Alparslan University (Other)
For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.
Outcome measures
Primary outcomes
- Physical Activity Level (Baseline, Week 4)
The participants' physical activity levels were evaluated with the International Physical Activity Questionnaire-Short Form (IPAQ-SF). The IPAQ-SF is a scale developed to determine the physical activity levels of participants aged 15-65 years and aims to obtain information about the time individuals spend in vigorous, moderate-to-vigorous activities and walking. The calculation of the IPAQ-SF total score includes the sum of the… - Physical Performance (Baseline, Week 4)
Short Physical Performance Battery (SPPB): The SPPB is calculated from three components: the ability to stand, time to complete a 3-m walk, and time to stand from a chair five times. Each part is scored out of 4, with the scores from the three tests calculated to give a total of 12 and a minimum of 0. Single-Leg Standing Test:… - Health-Related Quality of Life (Baseline, Week 4)
The health-related quality of life (HRQoL) was evaluated with the Short Form-36 (SF36). SF-36 is a patient-reported questionnaire developed and used to determine HRQoL. It is a self-assessment scale with generic criteria. In this study, SF-36 physical function and general health subscales were utilized. The subscales assess health on a 0-100 scale, with 0 indicating poor health and 100 indicating…
Related ClearedRx care
If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.
Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT06517771 before contacting a site.
ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.